YS43-22

(4S,4aS,5aS,13aS,15aS,15bR)-6-methyl-3,4,4a,5,5a,7,8,13a,15,15a,15b,16-dodecahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-6-ium-14-one,chloride

21α,22-Dihydrostrychnidine

19,22-Dimethyltetracontan

SF-22 (TRPML3 activator)

7,22-dihydro-8,21-dioxa-tetranaphtho[2,1-b:1',2'-d:2'',1''-h:1''',2'''-j]cyclododecene

Ergosten-(22)-triol-(3α,5α,8α)

N-(2-Acetyl-4-pyrrolidinophenyl)-4-benzyloxybenzamide

Ethyl 2-amino-3-(dimethylamino)-2-methylpropanoate

7-Fluoro-2,3,4,5-tetrahydro-1h-benzo[c]azepine

4-Iodo-N-[2-(methylsulfonyl)ethyl]benzenamine

6-Bromobenzofurano[2,3-c]dibenzofuran

2-Bromo-4-trifluoromethyl-6-trimethylsilanylethynyl-phenylamine

N'-hydroxy-2-(isopropylamino)acetamidine

3,3',5'-Triiodo-l-thyronine sodium

2-(2-Bromoethyl)-2,3-dihydropyridazin-3-one

2-(1H-indazole-3-carbonylamino)pentanedioic acid